People: Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

30 Oct 2020
Change (% chg)

€0.08 (+0.43%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Garnier, Jean-Pierre 

Dr. Jean-Pierre Garnier Ph.D. serves as Chairman of the Board of the Company. Jean-Pierre Garnier graduated from Louis Pasteur University (PhD in Pharmacology) and Stanford University (Master in Business Administration). He started his career in 1975 at the pharmaceutical company Schering-Plough where he held a number of management positions in Europe before becoming President of their American division. In 1990, he joined Smithkline Beecham Laboratories as President of the Pharmaceuticals Division and became President and CEO in 1999. In 2000, Jean-Pierre Garnier achieved the merge of two of the largest pharmaceutical groups (Smithkline Beecham and Glaxo Wellcome), to create GlaxoSmithKline (GSK), which he chaired until 2008. He was also Chairman of Actelion from 2011 to 2017. The Best Practice Institute has nominated Jean-Pierre Garnier as one of the world’s top 20 CEOs. He is an Officier de la Légion d’Honneur (Officer of the Legion of Honour) and Knight Commander of the Order of the British Empire.

Basic Compensation

Total Annual Compensation, EUR 53,653
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 53,653

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --